Electrospun Silk Fibroin–Ce6 Films for Photodynamic Antibacterial Wound Healing

Study Background and Research Question

Bacterial infections, particularly those caused by multidrug-resistant Staphylococcus aureus (S. aureus), pose a persistent challenge in the management of skin wounds. The widespread use of antibiotics has led to escalating resistance, while bacterial biofilm formation further impairs therapeutic success. Silk fibroin, a biocompatible natural polymer, is widely recognized for its applications in tissue engineering and wound dressings. However, its lack of intrinsic antibacterial activity limits its effectiveness in infection-prone environments. The reference study (Li et al., 2024) addresses a critical question: can silk fibroin biomaterials be engineered with integrated photodynamic therapy (PDT) capabilities to both eradicate bacteria and support wound healing?

Key Innovation from the Reference Study

The central innovation lies in fabricating an anisotropic silk fibroin film functionalized with Chlorin e6 (Ce6)–conjugated electrospun nanofibers. Ce6, a second-generation photosensitizer, was covalently attached to the aligned nanofiber matrix, resulting in a composite (SFCF@Film) that couples mechanical guidance for cell growth with potent, light-triggered antibacterial effects. This dual-functionality enables the film to serve as both a structural wound scaffold and an active agent against S. aureus infection upon near-infrared (NIR) irradiation.

Methods and Experimental Design Insights

The research team adopted a multi-step approach to construct the SFCF@Film:

• Silk fibroin was extracted and purified from silkworm cocoons to serve as the base matrix, leveraging its mechanical strength and biocompatibility.
• Chlorin e6 was chemically conjugated to the silk fibroin using established carbodiimide coupling chemistry, ensuring stable incorporation of the photosensitizer within the nanofiber structure.
• Electrospinning was utilized to fabricate aligned nanofibers, which were then layered onto a supporting silk fibroin film, yielding an anisotropic, biomimetic dressing.
• The composite’s physicochemical properties, hemocompatibility, and photodynamic activity were systematically characterized through spectroscopic, mechanical, and biological assays.

In vitro and in vivo models of S. aureus wound infection were employed to assess antibacterial efficacy and tissue repair outcomes upon NIR light activation.

Protocol Parameters

• Silk fibroin extraction: Degummed silkworm cocoons processed in lithium bromide, dialyzed, and lyophilized for purity.
• Ce6 conjugation: Carbodiimide (EDC/NHS) chemistry used for covalent attachment; Ce6 loading confirmed by UV–Vis absorption.
• Electrospinning: Silk fibroin–Ce6 solution spun at controlled voltage and flow rates to achieve fiber alignment.
• Photodynamic activation: NIR light (parameters optimized in study) applied for up to 10 minutes to trigger reactive oxygen species generation and antibacterial action.
• In vivo application: SFCF@Film applied to infected wound models; healing and immune response monitored post-irradiation.

Researchers may adapt these methods for similar biomaterial–photosensitizer conjugates, referencing specific Ce6 photodynamic workflows in related cancer or infection models (protocol guide).

Core Findings and Why They Matter

The SFCF@Film demonstrated several meaningful advances over conventional wound dressings and standalone photodynamic agents:

• Rapid and Effective Bacterial Eradication: Under NIR irradiation, the Ce6-functionalized film generated high levels of reactive oxygen species (ROS), achieving significant reduction of S. aureus biofilms within 10 minutes (Li et al., 2024).
• Promotion of Wound Healing: Beyond antibacterial activity, the anisotropic structure provided directional cues for cell migration and proliferation, supporting tissue regeneration.
• Immunomodulatory Effects: The film promoted M2 polarization of macrophages at later healing stages, suggesting a role in controlling inflammation and fostering tissue repair rather than chronic wound pathology.
• Hemocompatibility and Mechanical Integrity: The composite maintained favorable blood compatibility and mechanical properties suitable for wound dressing applications.

These findings collectively suggest that integrating Ce6-based photodynamic therapy into biomaterial scaffolds can address both infection control and tissue regeneration—a dual challenge in chronic or drug-resistant wound environments.

Comparison with Existing Internal Articles

Several recent articles contextualize these advances within broader Ce6 photosensitizer research. For instance, the guide on Chlorin e6 Photosensitizer: Protocols & Advanced PDT Workflows highlights how Ce6’s precise, light-triggered cytotoxicity is being adapted from cancer models to antimicrobial settings. Similarly, recent summaries emphasize the leap from molecular PDT to engineered biomaterials for wound healing. The current study builds on this momentum, offering a robust demonstration of how silk fibroin–Ce6 conjugates can overcome limitations of rapid photosensitizer clearance and poor tissue targeting, as discussed in these resources.

Moreover, mechanistic insights into ROS-mediated cellular apoptosis and immunogenic modulation—outlined in protocol and mechanism reviews—are reflected in the reference paper’s evidence for both bacterial killing and favorable immune polarization.

Limitations and Transferability

Despite promising results, several limitations merit consideration:

• Model Specificity: The in vivo antibacterial efficacy was demonstrated in murine wound infection models; translation to human wounds may require dose, irradiation, and safety optimization.
• Photosensitizer Stability: The long-term stability and release kinetics of Ce6 within the silk fibroin scaffold under physiological conditions remain to be fully characterized.
• Light Penetration: NIR activation is effective for shallow wounds, but deeper tissue infections may present challenges for sufficient light delivery.
• Scalability: Large-scale fabrication and standardization of anisotropic fiber alignment may impact reproducibility in clinical settings.

Nevertheless, the strategy is transferable to other biopolymer scaffolds and may be adapted for both antibacterial and anticancer photodynamic therapy with further validation.

Research Support Resources

Researchers interested in reproducing or extending this workflow can reference Chlorin e6 (Ce6) (SKU B8314) from APExBIO for PDT applications. This Ce6 product offers high solubility in DMSO and is supplied with rigorous quality control data, supporting advanced antibacterial or cancer research photodynamic therapy studies. For protocol adaptations, see the cited internal articles for detailed procedures and troubleshooting strategies.